1. Home
  2. NAZ vs SLGL Comparison

NAZ vs SLGL Comparison

Compare NAZ & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

HOLD

Current Price

$12.04

Market Cap

146.0M

Sector

Finance

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$70.00

Market Cap

159.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAZ
SLGL
Founded
1992
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.0M
159.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NAZ
SLGL
Price
$12.04
$70.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
18.3K
27.2K
Earning Date
01-01-0001
11-20-2025
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,970,000.00
Revenue This Year
N/A
$122.71
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.04
52 Week Low
$9.22
$4.02
52 Week High
$11.37
$76.80

Technical Indicators

Market Signals
Indicator
NAZ
SLGL
Relative Strength Index (RSI) 55.10 73.05
Support Level $11.95 $62.23
Resistance Level $12.08 $67.78
Average True Range (ATR) 0.07 6.33
MACD 0.00 0.20
Stochastic Oscillator 66.67 96.81

Price Performance

Historical Comparison
NAZ
SLGL

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: